Hims Appears in 74.0% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending Hair Loss Treatments. For more detail, you can also read Hair Loss Treatments: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- Hims appears in 534 of 722 benchmark answers, giving it strong reach in hair loss treatments but a lower recommendation share than Rogaine.
- Most conflicting claims cluster around pricing and finasteride concentration, and they should be verified against primary sources before any page changes.
- The company’s main hair-loss page and several supporting pages are cited often, making them priority candidates for fact-checked page briefs.
- Recorded buyer questions focus on whether treatments work and which hair growth products are best, suggesting clear content opportunities around existing demand.
Answer Capsule
In November 2026, Hims appeared in 534 of 722 AI answers included in the Hair Loss Treatments benchmark (73.96%). It received 322 recommendations (44.60%), with 262 Top 3 placements and 124 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Hims mentions, recommendations and placements compare with its Hair Loss Treatments peers?
Hims recorded 534 mentions (73.96%) and 322 recommendations (44.60%) across 722 answers included in the benchmark. Top 3 placements numbered 262; first-place recommendations numbered 124. Framing among its mentions was 346 positive, 186 neutral and 2 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Rogaine | 547 | 75.76% | 341 | 47.23% | 269 | 37.26% | 227 | 31.44% |
2 | Hims | 534 | 73.96% | 322 | 44.60% | 262 | 36.29% | 124 | 17.17% |
3 | Nutrafol | 395 | 54.71% | 274 | 37.95% | 203 | 28.12% | 30 | 4.16% |
4 | Happy Head | 220 | 30.47% | 156 | 21.61% | 122 | 16.90% | 10 | 1.39% |
5 | Keeps | 239 | 33.10% | 125 | 17.31% | 88 | 12.19% | 14 | 1.94% |
6 | Propecia (Merck) | 302 | 41.83% | 105 | 14.54% | 80 | 11.08% | 24 | 3.32% |
7 | Ro | 163 | 22.58% | 77 | 10.66% | 55 | 7.62% | 14 | 1.94% |
8 | Bosley | 56 | 7.76% | 11 | 1.52% | 6 | 0.83% | 2 | 0.28% |
9 | HairClub | 40 | 5.54% | 3 | 0.42% | 2 | 0.28% | 0 | 0.00% |
10 | Folexin | 2 | 0.28% | 2 | 0.28% | 2 | 0.28% | 1 | 0.14% |
Hims sits near the top of this category on reach, with mentions appearing in roughly three of every four answers. Its recommendation share trails the leader, so the gap is less about being seen than about being endorsed when the brand comes up. That distinction should shape where effort goes.
Placement is the sharper issue. Many appearances land in the top three, but far fewer take first place. The agency would build a scorecard separating reach, endorsement and placement so the client can see which lever is weakest before committing to content or outreach work.
Framing is overwhelmingly positive or neutral, with almost no negative wording. That is a healthy base, but it does not by itself confirm that the underlying product claims in answers are accurate.
What changed since last month
Questions This Section Answers
- How did Hims counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 534 / 722 (73.96%) |
Recommendations | 322 / 722 (44.60%) |
Top 3 recommendations | 262 / 722 (36.29%) |
#1 recommendations | 124 / 722 (17.17%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first broad baseline, built on a wider question set than the earlier editions. The current figures should be read as a starting reference point rather than as movement against a prior month, because the earlier samples are not comparable.
That means the agency would treat this month as the anchor for future comparison. The useful question is not what changed, but what the next edition measured on the same scope shows. Until then, no trend should be claimed.
Future reports using the same screening scope can be set against this baseline, which is where genuine month-to-month interpretation becomes possible.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- Himsno changeNov 202644.60%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Hims?
AI answers contained 3 conflicting claims about Hims: 0 critical, 0 high, 2 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
The answers contained a small set of conflicting claims about Hims, mostly rated medium priority. None were rated critical or high. That rating is a triage signal for fact-checking, not a finding that the company or any publisher got something wrong.
The agency would pair the visibility scorecard with a short list of claims worth verifying against current primary sources. Each claim gets an owner, a source requirement and a status, so the client can decide what to correct, what to leave and what needs more evidence before acting.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Hims should be verified before proposed page edits?
Review topic | Severity | Recorded AI claim A | Recorded AI claim B |
|---|---|---|---|
monthly price | low | $15–$35+/month | $15–$50+/month |
finasteride concentration in topical spray | medium | 0.3% finasteride | 0.25% finasteride |
monthly price of oral finasteride subscription | medium | $32/month | $16-$30/month |
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
The disputed topics cluster around pricing and the finasteride concentration in the topical spray. Both columns in the review table quote AI answers, not verified company facts, so neither side should be treated as correct until the entity, date and source are checked.
The agency would prepare conditional page briefs rather than corrections. Each brief would state the approved fact once verified, note any date sensitivity that could explain an apparent conflict, and hold the change until a primary source confirms it.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Hims?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://innerbody.com/nutrafol-vs-hims | 8 | 7 | 1 |
https://forbes.com/health/wellness/hims-hair-loss-review/ | 5 | 5 | 1 |
https://dermatologysense.com/dermatologists-advice/does-hims-work-for-hair-loss/ | 2 | 2 | 1 |
https://finvsfin.com/hims-vs-nutrafol/ | 2 | 2 | 1 |
https://drranairfan.com/hims-vs-nutrafol/ | 1 | 1 | 1 |
https://ro.co/hair-loss/how-much-does-finasteride-cost/ | 9 | 9 | 1 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
Several third-party pages appear alongside conflicting claims, including review sites and a competitor's cost page. A page linked to a claim is not necessarily its cause, and the current contents of these pages still need checking before any request is made.
The agency would review the selected pages directly, confirm what they currently say, and only then decide whether an evidence-backed correction request is justified. Where no error is found, the outcome is a documented no-change decision rather than an outreach attempt.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Hims website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://hims.com/hair-loss | 57 | 57 | 43 |
https://hims.com/blog/is-finasteride-over-the-counter | 26 | 26 | 9 |
https://hims.com/blog/hims-vs-keeps | 16 | 16 | 6 |
https://hims.com/blog/fda-approved-hair-growth-products | 11 | 11 | 8 |
https://hims.com/blog/finasteride-costs-pricing-guide | 10 | 10 | 0 |
https://hims.com/blog/minoxidil-vs-rogaine-differences | 8 | 8 | 3 |
https://hims.com/hair-loss/finasteride | 8 | 8 | 5 |
https://hims.com/blog/dermatologist-recommended-hair-growth-products | 7 | 7 | 3 |
The company's website was cited 283 times across 79 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
The company's own pages are cited widely, with the main hair-loss page drawing the most appearances and a large share of them in recommending answers. That makes it the natural first candidate for a page brief built on approved facts and real buyer questions.
Other cited pages vary in how often they appear alongside recommendations, and one pricing guide drew citations without recorded recommendations. The agency would check existing coverage before proposing new pages, and would brief priority pages around verified claims and the questions buyers actually ask.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Hims?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
Do Hims and keeps actually work? | 6 | 6 | 3 |
What is the best topical finasteride brand? | 4 | 4 | 3 |
What is the best Hair Growth Accelerator? | 3 | 3 | 3 |
What is the best hair growth product for men? | 3 | 3 | 3 |
What is the best hair growth product that actually works? | 3 | 3 | 3 |
What is the best hair growth product that works? | 3 | 3 | 3 |
What is the best hair growth treatment for men? | 3 | 3 | 3 |
What is the best hair product for regrowth? | 3 | 3 | 3 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions are practical: whether the treatments work, which topical finasteride brand is best, and which products suit men. Hims appears in all of them and is recommended in most, which suggests the content opportunity is about answering these questions clearly rather than chasing new topics.
These are answer observations, not search volume or proof of missing pages. The agency would check existing coverage first, then draft buyer-question briefs only where a genuine gap or weak answer exists.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Hims work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline scorecard, a scoped fact-review list and a shortlist of pages and sources, each with an owner and review status. The second month turns approved findings into page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately.
The final month produces buyer-content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, and no visibility gain is promised, since the plan tracks what was delivered and what the next measurement shows.
Methodology
Questions This Section Answers
- How are Hims answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 722 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 6305 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 722 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. Earlier editions (September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The visibility rates rest on answers that met the benchmark's inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording. Top-three and first-place counts sit inside those recommendations rather than adding to them.
Answers can mention several companies, so company counts do not sum to distinct answers. The exact collection dates for the original answers are unverified, and the current contents of cited pages and disputed claims still need independent checking.
Our first three priorities
First, verify the disputed pricing and finasteride-concentration claims against current primary sources before any correction is considered, and keep ambiguous matches out of the queue. Second, brief the main hair-loss page and the most-cited supporting pages around approved facts and the buyer questions recorded here.
Third, review the selected third-party pages directly and issue evidence-backed requests only where a real error is confirmed. Together these give the client a defensible base for the next measurement without overstating what this edition shows.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending Hair Loss Treatments. For more detail, you can also read Hair Loss Treatments: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


